Wheelchair denials in California external review

In the California DMHC record, independent physician reviewers decided 141 published external-review cases involving Wheelchairand overturned the plan’s denial in 27%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
141
2002–2026
Overturned
27%
38 denials reversed

Conditions behind Wheelchair denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Paralysis20
30%
Cerebral Palsy15
66.7%
Multiple Sclerosis9
11.1%
Osteoarthritis8
12.5%
Back Pain8
0%
Amputation5
40%
Muscular Dystrophy3
33.3%
Vertebral Disc Prob3
0%
Diabetes3
33.3%
Typical time to a decision
19 days
Most land between 11 and 21 days
Handled as urgent
14.9%
Expedited when a delay would cause harm
Recent direction
Falling
38.5%29.4% overturned, last three years

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for ultralightweight wheelchair (HCPCS K0005), skin protection wheelchair seat cushion width 22 inches, any depth (HCPCS E2622), manual wheelchair accessory, pneumatic propulsion tire, any size x 2 (HCPCS Codes E2211), and pneumatic propulsion tire insert x 2 (HCPCS E2213). The records provided for review document that this patient is non-ambulatory due to sacral level spina bifida with chronic paraplegia, as well as due to her talipes equinovarus. She requires a wheelchair to perform all of her mobility-related activities of daily living and instrumental activities of daily living, as well as for community access. The patient’s upper limbs are reported to be functionally intact.
Medical Necessity · 2022 · IMR MN22-37036
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for Wheelchair accessories [two-sided ABS footrest cover; titanium frame; push handles; Spinergy LX performance wheels; natural fit hand rims; side guards; scissor lock brakes; and/or custom fabricated seat cushion] for the authorized ultra-lightweight manual wheelchair with Smart Drive power assist. This patient presents with a medical history of T6 paraplegia since 1992. The records document that the patient has been experiencing bilateral arm pain and she has a neurogenic bladder. The patient’s provider has recommended a new manual wheelchair. A physical therapy assessment performed on 6/25/23 indicated that the patient’s current wheelchair is old, too small, and falling apart.
Medical Necessity · 2023 · IMR MN23-40121

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Findings: The physician reviewer found that The patient is a 51-year-old individual with a history of multiple sclerosis. The patient is reported to have been initially diagnosed with multiple sclerosis in 2003 (relapsing-remitting type). Subsequently The patient acquired a COVID-19 infection. The patient is reported to have been hospitalized for approximately one month and experienced paralysis, muscle loss, and weight loss. Records from The patient primary care provider indicated that the patient had diarrhea, right-sided weakness, and multiple syncopal episodes (most likely due to hypovolemia) during hospitalization. The patient was discharged back to the community with a hospital-grade manual wheelchair which was difficult and painful to self-propel due to its weight and configuration.
Medical Necessity · 2023 · IMR MN23-38772
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for durable medical equipment (DME) power wheelchair accessories including power seating system, center mount elevating leg/platform complete system and power standing system. Findings: The physician reviewer found that Multiple sclerosis is an immune-mediated, demyelinating and neurodegenerative disease of the central nervous system that is a major cause of chronic neurological disability in young and middle-aged adults. Treatment involves controlling acute attacks, managing and preventing underlying disease progression, managing symptomatology, and managing the progressive functional impairments associated with the disease.
Medical Necessity · 2021 · IMR MN21-34993

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Wheelchair, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Wheelchair? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9